Suppr超能文献

免疫显性甲型流感病毒M158 - 66细胞毒性T淋巴细胞表位在人类中表现出I类主要组织相容性复合体的简并性限制。

The immunodominant influenza A virus M158-66 cytotoxic T lymphocyte epitope exhibits degenerate class I major histocompatibility complex restriction in humans.

作者信息

Choo Joanna A L, Liu Jingxian, Toh Xinyu, Grotenbreg Gijsbert M, Ren Ee Chee

机构信息

Department of Microbiology, National University of Singapore, Singapore Immunology Programme, National University of Singapore, Singapore.

Singapore Immunology Network, A*STAR, Singapore.

出版信息

J Virol. 2014 Sep;88(18):10613-23. doi: 10.1128/JVI.00855-14. Epub 2014 Jul 2.

Abstract

UNLABELLED

Cytotoxic T lymphocytes recognizing conserved peptide epitopes are crucial for protection against influenza A virus (IAV) infection. The CD8 T cell response against the M158-66 (GILGFVFTL) matrix protein epitope is immunodominant when restricted by HLA-A02, a major histocompatibility complex (MHC) molecule expressed by approximately half of the human population. Here we report that the GILGFVFTL peptide is restricted by multiple HLA-C08 alleles as well. We observed that M158-66 was able to elicit cytotoxic T lymphocyte (CTL) responses in both HLA-A02- and HLA-C08-positive individuals and that GILGFVFTL-specific CTLs in individuals expressing both restriction elements were distinct and not cross-reactive. The crystal structure of GILGFVFTL-HLA-C08:01 was solved at 1.84 Å, and comparison with the known GILGFVFTL-HLA-A02:01 structure revealed that the antigen bound both complexes in near-identical conformations, accommodated by binding pockets shaped from shared as well as unique residues. This discovery of degenerate peptide presentation by both HLA-A and HLA-C allelic variants eliciting unique CTL responses to IAV infection contributes fundamental knowledge with important implications for vaccine development strategies.

IMPORTANCE

The presentation of influenza A virus peptides to elicit immunity is thought to be narrowly restricted, with a single peptide presented by a specific HLA molecule. In this study, we show that the same influenza A virus peptide can be more broadly presented by both HLA-A and HLA-C molecules. This discovery may help to explain the differences in immunity to influenza A virus between individuals and populations and may also aid in the design of vaccines.

摘要

未标记

识别保守肽表位的细胞毒性T淋巴细胞对于预防甲型流感病毒(IAV)感染至关重要。当受HLA - A02限制时,针对M158 - 66(GILGFVFTL)基质蛋白表位的CD8 T细胞反应具有免疫优势,HLA - A02是一种主要组织相容性复合体(MHC)分子,约一半的人类表达该分子。在此我们报告,GILGFVFTL肽也受多种HLA - C08等位基因限制。我们观察到,M158 - 66能够在HLA - A02阳性和HLA - C08阳性个体中引发细胞毒性T淋巴细胞(CTL)反应,并且在同时表达这两种限制元件的个体中,GILGFVFTL特异性CTL是不同的,且无交叉反应性。GILGFVFTL - HLA - C08:01的晶体结构在1.84 Å分辨率下解析,与已知的GILGFVFTL - HLA - A*02:01结构比较显示,抗原以近乎相同的构象结合这两种复合体,由共享以及独特残基形成的结合口袋容纳。HLA - A和HLA - C等位基因变体呈现简并肽引发对IAV感染的独特CTL反应这一发现,为疫苗开发策略提供了具有重要意义的基础知识。

重要性

甲型流感病毒肽引发免疫的呈递被认为受到严格限制,即由特定HLA分子呈递单一肽。在本研究中,我们表明相同的甲型流感病毒肽可由HLA - A和HLA - C分子更广泛地呈递。这一发现可能有助于解释个体和群体对甲型流感病毒免疫的差异,也可能有助于疫苗设计。

相似文献

4
Structural basis for clonal diversity of the human T-cell response to a dominant influenza virus epitope.
J Biol Chem. 2017 Nov 10;292(45):18618-18627. doi: 10.1074/jbc.M117.810382. Epub 2017 Sep 20.

引用本文的文献

1
Ancient trans-species polymorphism at the Major Histocompatibility Complex in primates.
Elife. 2025 Sep 12;14:RP103547. doi: 10.7554/eLife.103547.
3
Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines.
Immune Netw. 2024 May 7;24(3):e19. doi: 10.4110/in.2024.24.e19. eCollection 2024 Jun.
5
CD8 T-cell responses towards conserved influenza B virus epitopes across anatomical sites and age.
Nat Commun. 2024 Apr 29;15(1):3387. doi: 10.1038/s41467-024-47576-y.
6
Validation of Multi-epitope Peptides Encapsulated in PLGA Nanoparticles Against Influenza A Virus.
Pharm Res. 2023 Aug;40(8):1999-2025. doi: 10.1007/s11095-023-03540-x. Epub 2023 Jun 21.
7
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT.
Blood Adv. 2023 May 9;7(9):1635-1649. doi: 10.1182/bloodadvances.2022008863.
9
Immunogenic epitope prediction to create a universal influenza vaccine.
Heliyon. 2022 Apr 30;8(5):e09364. doi: 10.1016/j.heliyon.2022.e09364. eCollection 2022 May.
10
Human SUMOylation Pathway Is Critical for Influenza B Virus.
Viruses. 2022 Feb 3;14(2):314. doi: 10.3390/v14020314.

本文引用的文献

1
Preexisting CD8+ T-cell immunity to the H7N9 influenza A virus varies across ethnicities.
Proc Natl Acad Sci U S A. 2014 Jan 21;111(3):1049-54. doi: 10.1073/pnas.1322229111. Epub 2014 Jan 6.
2
HLA micropolymorphisms strongly affect peptide-MHC multimer-based monitoring of antigen-specific CD8+ T cell responses.
J Immunol. 2014 Jan 15;192(2):641-8. doi: 10.4049/jimmunol.1301770. Epub 2013 Dec 16.
4
Cellular immune correlates of protection against symptomatic pandemic influenza.
Nat Med. 2013 Oct;19(10):1305-12. doi: 10.1038/nm.3350. Epub 2013 Sep 22.
5
Population-specific recombination sites within the human MHC region.
Heredity (Edinb). 2013 Aug;111(2):131-8. doi: 10.1038/hdy.2013.27. Epub 2013 May 29.
8
Overview of the CCP4 suite and current developments.
Acta Crystallogr D Biol Crystallogr. 2011 Apr;67(Pt 4):235-42. doi: 10.1107/S0907444910045749. Epub 2011 Mar 18.
9
T cell-mediated protection against lethal 2009 pandemic H1N1 influenza virus infection in a mouse model.
J Virol. 2011 Jan;85(1):448-55. doi: 10.1128/JVI.01812-10. Epub 2010 Oct 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验